| Molecular characterisation of pancreatic ductal adenocarcinoma with NTRK fusions and review of the literature MJ Allen, A Zhang, P Bavi, JC Kim, GH Jang, D Kelly, S Perera, ... Journal of Clinical Pathology 76 (3), 158-165, 2023 | 17 | 2023 |
| hENT1 expression predicts response to gemcitabine and nab-paclitaxel in advanced pancreatic ductal adenocarcinoma S Perera, GH Jang, Y Wang, D Kelly, M Allen, A Zhang, RE Denroche, ... Clinical Cancer Research 28 (23), 5115-5120, 2022 | 14 | 2022 |
| Combined 18F-FDG PET/CT radiomics and sarcopenia score in predicting relapse-free survival and overall survival in patients with esophagogastric cancer R Anconina, C Ortega, U Metser, ZA Liu, E Elimova, M Allen, GE Darling, ... Clinical Nuclear Medicine 47 (8), 684-691, 2022 | 13 | 2022 |
| Prognostic significance of nutritional markers in metastatic gastric and esophageal adenocarcinoma LX Ma, K Taylor, O Espin‐Garcia, R Anconina, C Suzuki, MJ Allen, ... Cancer Medicine 10 (1), 199-207, 2021 | 13 | 2021 |
| Retrospective analysis of hospital admissions due to immune checkpoint inhibitor‐induced immune‐related adverse events (irAE) E Ahern, MJ Allen, A Schmidt, Z Lwin, BGM Hughes Asia‐Pacific Journal of Clinical Oncology 17 (2), e109-e116, 2021 | 11 | 2021 |
| Systemic inflammatory prognostic scores in advanced pancreatic adenocarcinoma LX Ma, Y Wang, O Espin-Garcia, MJ Allen, GH Jang, A Zhang, A Dodd, ... British Journal of Cancer 128 (10), 1916-1921, 2023 | 8 | 2023 |
| CANDIED: a pan-Canadian cohort of immune checkpoint inhibitor-induced insulin-dependent diabetes mellitus TP Muniz, DV Araujo, KJ Savage, T Cheng, M Saha, X Song, S Gill, ... Cancers 14 (1), 89, 2021 | 6 | 2021 |
| Comparison of four clinical prognostic scores in patients with advanced gastric and esophageal cancer LX Ma, O Espin-Garcia, Y Bach, H Aoyama, MJ Allen, X Wang, GE Darling, ... The Oncologist 28 (3), 214-219, 2023 | 5 | 2023 |
| A review of current adjuvant and neoadjuvant systemic treatments for cholangiocarcinoma and gallbladder carcinoma MJ Allen, JJ Knox Hepatoma Res 7 (7), 73, 2021 | 5 | 2021 |
| End‐of‐life intravenous chemotherapy administration patterns in the treatment of Queensland lung and pancreas cancer patients: a 10‐year retrospective analysis MJ Allen, N Dunn, T Guan, J Harrington, E Walpole Internal Medicine Journal 52 (4), 623-632, 2022 | 4 | 2022 |
| Preoperative and postoperative approaches to gastroesophageal cancer: what is all the fuss about LX Ma, ED Panov, MJ Allen, GE Darling, JC Yeung, CJ Swallow, SS Brar, ... Journal of the National Comprehensive Cancer Network 20 (2), 193-202, 2022 | 4 | 2022 |
| Homologous recombination deficiency (HRD) scoring in pancreatic ductal adenocarcinoma (PDAC) and response to chemotherapy. GM O'Kane, R Denroche, SL Picardo, A Zhang, S Holter, RC Grant, ... Journal of Clinical Oncology 38 (4_suppl), 741-741, 2020 | 4 | 2020 |
| Assessing treatment tolerability after geriatric assessment in the senior oncology clinic at the gold coast university hospital J Fletcher, J Sanmugarajah, S Caird, M Allen, A Quennell, M Powell Asia-Pacific Journal of Clinical Oncology 13, 122-122, 2017 | 4 | 2017 |
| Efficacy and safety of lenvatinib in the real-world treatment of hepatocellular carcinoma: Results from a Canadian multicenter database (HCC CHORD). CP Amaro, MJ Allen, JJ Knox, ES Tsang, HJ Lim, RM Lee-Ying, J Qian, ... Journal of Clinical Oncology 39 (3_suppl), 275-275, 2021 | 3 | 2021 |
| Gastric and gastroesophageal adenocarcinoma survival outcomes relative to completion of perioperative fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT): A single … MJ Allen, O Espin-Garcia, ED Panov, LX Ma, C Suzuki, Y Bach, ... Journal of Clinical Oncology 39 (3_suppl), 224-224, 2021 | 3 | 2021 |
| Outcomes and Immunogenicity of pancreatic cancer stratified by the HRDetect score. GM O'Kane, GH Jang, R Denroche, A Zhang, SL Picardo, RC Grant, ... Journal of Clinical Oncology 38 (15_suppl), 4630-4630, 2020 | 3 | 2020 |
| Impact of sites of metastatic dissemination on survival in advanced gastroesophageal adenocarcinoma X Wang, O Espin-Garcia, DM Jiang, MJ Allen, LX Ma, Y Bach, EX Chen, ... Oncology 100 (8), 439-448, 2022 | 2 | 2022 |
| Genomic sequencing to inform therapy in advanced pancreatic cancer: A systematic review and meta-analysis of prospective studies N Meti, D Kelly, MJ Allen, A Lanys, R Fazelzad, R Ramjeesingh, ... Cancer Treatment Reviews 101, 102310, 2021 | 2 | 2021 |
| Dosing, efficacy and safety of lenvatinb in the real‐world treatment of hepatocellular carcinoma: Results from a Canadian database C Pires Amaro, MJ Allen, JJ Knox, ES Tsang, HJ Lim, RM Lee‐Ying, ... Liver Cancer International 3 (3), 119-127, 2022 | 1 | 2022 |
| Comparison of systematic inflammatory prognostic scores in patients with advanced pancreatic adenocarcinoma. LX Ma, O Espin-Garcia, Y Wang, MJ Allen, GH Jang, A Zhang, A Dodd, ... Journal of Clinical Oncology 40 (16_suppl), 4149-4149, 2022 | 1 | 2022 |
